Original Article
Author Details :
Volume : 9, Issue : 3, Year : 2023
Article Page : 147-152
https://doi.org/10.18231/j.ijced.2023.027
Abstract
Background: Chronic urticaria (CU) places a substantial physical and emotional strain on individuals, impacting their overall quality of life. Alexithymia, described as difficulty experiencing, identifying and expressing emotions, is a characteristic linked to various skin conditions including CU. This study was carried out to assess how alexithymia compares between patients with chronic urticaria and individuals without the condition.
Materials and Methods: We included a total of 50 individuals with chronic urticaria (CU) and 50 healthy individuals as controls. All participants were asked to complete the Toronto Alexithymia Score (TAS-20) questionnaire as part of the study assessment.
Result: In our study we found the following patterns within the chronic urticaria (CU) group: 52% exhibited clear characteristics of alexithymia, 30% showed potential signs of alexithymia and 18% of participants had no indications of alexithymia. Among those who displayed alexithymia, the majority (88.5%) were in the non-controlled CU group category. When we examined the TAS-20 categories, we noticed gender differences among participants with alexithymia: 57.1% were female and 45.5% were male, suggesting a female predominance. In the control group, TAS-20 categorization revealed the following: 52% of participants had no alexithymia, 32% displayed potential alexithymia and 16% showed signs of alexithymia.
Conclusion: Individuals with chronic urticaria (CU) tend to exhibit higher levels of alexithymia, particularly in the DIF (Difficulty Identifying Feelings) and DDF (Difficulty Describing Feelings) subscales, when compared to individuals in the control population.
Keywords: Chronic urticaria, Alexithymia, Toronto Alexithymia Scale (TAS20)
How to cite : Ansari H, Maganbhai B A, Gurjar N, Patil S, Godse K, A case -control study on the effect of alexithymia in patients of chronic urticarial. IP Indian J Clin Exp Dermatol 2023;9(3):147-152
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Received : 12-06-2023
Accepted : 16-09-2023
Viewed: 557
PDF Downloaded: 146